(Q51914613)

17 April 2018

title

Interferon-alpha as angiogenesis inhibitor: learning from tumor models. (English)

1 reference

17 April 2018

main subject

angiogenesis inhibitor

1 reference

1

1 reference

17 April 2018

publication date

1 April 2010

1 reference

17 April 2018

published in

Autoimmunity

1 reference

17 April 2018

volume

43

1 reference

17 April 2018

issue

3

1 reference

17 April 2018

page(s)

244-247

1 reference

17 April 2018

Interferon-alpha in tumor immunity and immunotherapy

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

The interferons: 50 years after their discovery, there is much more to learn

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Angiogenesis meets immunology: cytokine gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Interferon-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510963

10.3109/08916930903510963

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

20166871

1 reference

17 April 2018